MX373765B - Composiciones y metodos para aumentar el rendimiento reproductivo en mamiferos no humanos utilizando una hormona foliculoestimulante recombinante (rfsh) biologicamente activa. - Google Patents
Composiciones y metodos para aumentar el rendimiento reproductivo en mamiferos no humanos utilizando una hormona foliculoestimulante recombinante (rfsh) biologicamente activa.Info
- Publication number
- MX373765B MX373765B MX2015006141A MX2015006141A MX373765B MX 373765 B MX373765 B MX 373765B MX 2015006141 A MX2015006141 A MX 2015006141A MX 2015006141 A MX2015006141 A MX 2015006141A MX 373765 B MX373765 B MX 373765B
- Authority
- MX
- Mexico
- Prior art keywords
- rfsh
- methods
- compositions
- biologically active
- stimulating hormone
- Prior art date
Links
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title abstract 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title abstract 2
- 229940028334 follicle stimulating hormone Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000001850 reproductive effect Effects 0.000 title 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000283073 Equus caballus Species 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306428.9A EP2732824A1 (en) | 2012-11-16 | 2012-11-16 | Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone |
| PCT/EP2013/073928 WO2014076231A1 (en) | 2012-11-16 | 2013-11-15 | Single dose recombinant bovine fsh after follicular synchronisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015006141A MX2015006141A (es) | 2015-08-05 |
| MX373765B true MX373765B (es) | 2020-03-24 |
Family
ID=47221997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015006141A MX373765B (es) | 2012-11-16 | 2013-11-15 | Composiciones y metodos para aumentar el rendimiento reproductivo en mamiferos no humanos utilizando una hormona foliculoestimulante recombinante (rfsh) biologicamente activa. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150335713A1 (enExample) |
| EP (3) | EP2732824A1 (enExample) |
| JP (2) | JP6419707B2 (enExample) |
| CN (2) | CN110433281A (enExample) |
| AU (1) | AU2013346803B2 (enExample) |
| ES (1) | ES2743763T3 (enExample) |
| MX (1) | MX373765B (enExample) |
| RU (1) | RU2679944C2 (enExample) |
| WO (1) | WO2014076231A1 (enExample) |
| ZA (1) | ZA201503404B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2782584T3 (pl) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Naturalne skojarzone hormonalne formulacje i terapie zastępcze |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| MX2016014281A (es) | 2014-05-22 | 2017-02-22 | Therapeuticsmd Inc | Formulaciones y terapias de reemplazo de combinación de hormonas naturales. |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| CN105727260A (zh) * | 2016-02-03 | 2016-07-06 | 华侨大学 | 一种卵泡刺激素的长效制剂 |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| US11376220B2 (en) | 2017-06-30 | 2022-07-05 | Therio, LLC | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals |
| CN107173329A (zh) * | 2017-07-07 | 2017-09-19 | 宣汉县蜀宣花牛养殖专业合作社 | 一种蜀宣花牛母牛繁殖方法 |
| CL2018001347A1 (es) * | 2018-05-18 | 2019-03-15 | Centro De Biotecnologia Y Biomedicina Spa 94% | Hormona folículo estimulante bovina recombinante, composición que la comprende y método para inducir superovulación y sincronización del celo en bovinos utilizando dicha hormona |
| CN114258302A (zh) * | 2019-08-01 | 2022-03-29 | 法国诗华大药厂 | 用于预防和/或治疗隐孢子虫病的兽用组合物 |
| EP4504238A1 (en) | 2022-04-01 | 2025-02-12 | Ceva Santé Animale | Increase of ovum pick-up in bos taurus |
| WO2023187160A1 (en) | 2022-04-01 | 2023-10-05 | Ceva Sante Animale | Stimulation of superovulation in bos taurus |
| CN116027053B (zh) * | 2022-09-27 | 2024-10-08 | 华中农业大学 | 一种竞争型草鱼卵泡刺激素检测试剂盒及应用 |
| CN117089512A (zh) * | 2023-08-21 | 2023-11-21 | 山东奥克斯畜牧种业有限公司 | 一种促进卵泡同步发育的制剂及牛体外胚胎生产方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1729352A1 (ru) * | 1987-11-25 | 1992-04-30 | Украинский Научно-Исследовательский Институт Физиологии И Биохимии Сельскохозяйственных Животных | Способ вызывани полиовул ции у коров-доноров при трансплантации эмбрионов |
| US6238890B1 (en) | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
| US5589457A (en) | 1995-07-03 | 1996-12-31 | Ausa International, Inc. | Process for the synchronization of ovulation |
| JPH09104638A (ja) * | 1995-10-06 | 1997-04-22 | Mitsui Pharmaceut Inc | 医薬・動物薬組成物 |
| US20090036384A1 (en) | 2005-12-02 | 2009-02-05 | Parnell Laboratories (Aust) Pty Limited | Increasing pregnancy rates |
| US8518881B2 (en) | 2007-02-08 | 2013-08-27 | Aspenbio Pharma, Inc. | Methods for inducing superovulation in ungulates |
| BRPI0821097A2 (pt) | 2007-11-30 | 2017-05-23 | Aspenbio Pharma Inc | aitividade de hormônio equino folículo estimulante recombinante |
| WO2009103965A1 (en) * | 2008-02-19 | 2009-08-27 | Asterion Limited | Modified linkers |
| JP5435422B2 (ja) * | 2009-07-21 | 2014-03-05 | 独立行政法人農業・食品産業技術総合研究機構 | ウシの発情同期化法およびそのためのキット |
-
2012
- 2012-11-16 EP EP12306428.9A patent/EP2732824A1/en not_active Withdrawn
-
2013
- 2013-11-15 MX MX2015006141A patent/MX373765B/es active IP Right Grant
- 2013-11-15 JP JP2015542272A patent/JP6419707B2/ja active Active
- 2013-11-15 WO PCT/EP2013/073928 patent/WO2014076231A1/en not_active Ceased
- 2013-11-15 EP EP13791813.2A patent/EP2919803B1/en active Active
- 2013-11-15 ES ES13791813T patent/ES2743763T3/es active Active
- 2013-11-15 CN CN201910624749.6A patent/CN110433281A/zh active Pending
- 2013-11-15 AU AU2013346803A patent/AU2013346803B2/en active Active
- 2013-11-15 RU RU2015122887A patent/RU2679944C2/ru active
- 2013-11-15 EP EP19151721.8A patent/EP3520807A1/en not_active Withdrawn
- 2013-11-15 CN CN201380060063.XA patent/CN104918631A/zh active Pending
- 2013-11-15 US US14/443,193 patent/US20150335713A1/en not_active Abandoned
-
2015
- 2015-05-15 ZA ZA2015/03404A patent/ZA201503404B/en unknown
-
2018
- 2018-07-06 JP JP2018129177A patent/JP6823013B2/ja active Active
-
2019
- 2019-03-21 US US16/360,285 patent/US20190200587A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2743763T3 (es) | 2020-02-20 |
| EP3520807A1 (en) | 2019-08-07 |
| JP2016502523A (ja) | 2016-01-28 |
| AU2013346803A1 (en) | 2015-05-21 |
| CN104918631A (zh) | 2015-09-16 |
| JP2018168189A (ja) | 2018-11-01 |
| ZA201503404B (en) | 2016-08-31 |
| WO2014076231A1 (en) | 2014-05-22 |
| RU2015122887A (ru) | 2017-01-10 |
| US20150335713A1 (en) | 2015-11-26 |
| JP6419707B2 (ja) | 2018-11-07 |
| JP6823013B2 (ja) | 2021-01-27 |
| US20190200587A1 (en) | 2019-07-04 |
| EP2732824A1 (en) | 2014-05-21 |
| RU2679944C2 (ru) | 2019-02-14 |
| EP2919803B1 (en) | 2019-05-08 |
| CN110433281A (zh) | 2019-11-12 |
| MX2015006141A (es) | 2015-08-05 |
| AU2013346803B2 (en) | 2018-03-15 |
| EP2919803A1 (en) | 2015-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX373765B (es) | Composiciones y metodos para aumentar el rendimiento reproductivo en mamiferos no humanos utilizando una hormona foliculoestimulante recombinante (rfsh) biologicamente activa. | |
| ES2540858T3 (es) | Composición farmacéutica para el tratamiento y/o la prevención de cáncer | |
| ES2606173T3 (es) | Composición farmacéutica para el tratamiento y/o la prevención del cáncer | |
| UY33647A (es) | ?agentes de unión a cd33?. | |
| ECSP15014133A (es) | Polipéptidos que contienen fc con glicosilación alterada y función efectora reducida | |
| MX380555B (es) | Combinación de anticuerpos anti-gen 3 de la activación de linfocito (lag-3) y anticuerpos anti-muerte celular programada 1 (pd-1) para usarse en el tratamiento de tumores. | |
| BR112015021371A2 (pt) | uso de agonistas de receptor de formil peptídeo 2 para tratar doenças inflamatórias oculares | |
| MX2021014954A (es) | Composiciones y metodos para la degradacion de proteinas mal plegadas. | |
| AR070633A1 (es) | Metodos para modificar el punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en la region de determinacion de la complementariedad (cdr) | |
| GT201400056A (es) | Proteínas de función dual para tratar trastornos metabolicos | |
| HK1217762A1 (zh) | 用於評價卵母細胞和胚胎的代謝成像方法 | |
| CO6640254A2 (es) | Método para preparar anticuerpos con propiedades mejoradas | |
| AR060487A1 (es) | Composiciones farmaceuticas de antagonistas del anticuerpo anti- cd40 | |
| NZ708453A (en) | Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants | |
| MX2017016322A (es) | Metodos para tratar tumores de celulas epitelioides. | |
| ES2721882T3 (es) | Regiones constantes de anticuerpo modificadas por ingeniería genética para conjugación específica de sitio y procedimientos y usos de las mismas | |
| AR092076A1 (es) | Proteinas homodimericas | |
| CL2017002729A1 (es) | Proteína de unión a rgma y su uso | |
| CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
| CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| BR112015020290A2 (pt) | métodos para tratar um câncer, para prevenir câncer, para inibir proliferação, para tratar terapeuticamente um mamífero, para tratar uma disfunção, para reduzir níveis de proteína spp1, para tratar terapeuticamente um câncer, para tratar um indivíduo e para inibir proliferação celular, artigo, anticorpos e usos | |
| MX2013006406A (es) | Gel multiusos para sequedad vaginal con efecto directo y retardado. | |
| UY31810A (es) | Encapsulación de agentes biológicamente activos | |
| WO2008098169A3 (en) | Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone | |
| AR083126A1 (es) | Composicion vacunal para el control de las infestaciones por ectoparasitos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |